Search
Search Results
##search.searchResults.foundPlural##
-
EPIDEMIOLOGICAL OVERVIEW OF HODGKIN LYMPHOMA ACROSS THE MEDITERRANEAN BASIN
3451PDF: 1138HTML: 4976Incidence age-standardized rates for HL across the Mediterranean basin: 179 -
THERAPY-RELATED MYELOID NEOPLASM IN NON-HODGKIN LYMPHOMA SURVIVORS
2525PDF: 712HTML: 2283 -
ACUTE LUNG INJURY COMPLICATING BLOOD TRANSFUSION IN POST-PARTUM HEMORRHAGE: INCIDENCE AND RISK FACTORS.
2350PDF: 1181HTML: 3584Acute lung injury complicating blood transfusion in post-partum hemorrhage: incidence and risk factors.: 396 -
TUBERCULOSIS IN TROPICAL AREAS AND IMMIGRANTS
3235PDF: 1276HTML: 6172 -
CMV IN HEMATOPOIETIC STEM CELL TRANSPLANTATION
4727PDF: 1719HTML: 2687Untitled: 194 -
CONCISE REVIEW ON THE FREQUENCY, MAJOR RISK FACTORS AND SURVEILLANCE OF HEPATOCELLULAR CARCINOMA (HCC) IN ?-THALASSEMIAS: PAST, PRESENT AND FUTURE PERSPECTIVES Thalassaemia transfusion dependent, Hepatitis C, hepatocarcinoma.
4153PDF: 1492HTML: 431 -
UPDATE ON CYTOMEGALOVIRUS INFECTION MANAGEMENT IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS A Consensus Document of the Spanish Group for Hematopoietic Transplantation and Cell Therapy (GETH-TC)
3768Suppl. Files: 1050PDF: 1025Html: 112 -
CLONAL HEMATOPOIESIS: ROLE IN HEMATOLOGIC NON-HEMATOLOGIC MALIGNANCIES CLONAL HEMATOPOIESIS AND MALIGNANCIES
1898PDF: 840HTML: 1286 -
COMPARISON OF INFECTIOUS COMPLICATIONS IN PATIENTS RECEIVING HIGH-DOSE CYCLOPHOSPHAMIDE AS GVHD AFTER TRANSPLANTATION FROM A 9/10 HLA-MATCHED UNRELATED DONOR WITH STANDARD GVHD PROPHYLAXIS AFTER TRANSPLANT FROM A FULL MATCHING DONOR Infection With PTCy Versus Standard GvHD Prophylaxis
1332PDF: 1271HTML: 80 -
INCIDENCE OF ACUTE MYELOID LEUKEMIA AFTER BREAST CANCER
3174PDF: 907HTML: 2929 -
BACTERIAL INFECTIONS IN HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS
3047PDF: 1782HTML: 3545 -
-
TUBERCULOSIS IN HEMATOPOIETIC STEM CELL TRANSPLANT PATIENTS.
2569PDF: 914HTML: 3583 -
MANAGEMENT OF ACUTE PROMYELOCYTIC LEUKEMIA IN THE ELDERLY
2709PDF: 1076HTML: 3255 -
OCCURRENCE OF SECONDARY MALIGNANCIES IN CHRONIC MYELOID LEUKEMIA DURING THERAPY WITH IMATINIB MESYLATE-SINGLE INSTITUTION EXPERIENCE
2178PDF: 1008HTML: 1972Characteristic of study group: 180 -
VIRAL HEPATITIS A TO E IN SOUTH MEDITERRANEAN COUNTRIES
1206PDF: 634HTML: 7710 -
TUBERCULOSIS: EPIDEMIOLOGY AND CONTROL
6778PDF: 3842HTML: 24853 -
HEMATOPOIETIC CELL TRANSPLANTATION FOR OLDER PATIENTS WITH MDS
1953PDF: 739HTML: 3102 -
ANTIFUNGAL THERAPY IN HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS
4665PDF: 1513HTML: 2232Untitled: 191Untitled: 208Untitled: 213Untitled: 197Untitled: 197 -
HIV-ASSOCIATED VENOUS THROMBOEMBOLISM
3802PDF: 1434HTML: 8488 -
SIMILARITIES OF ELDERLY AND THERAPY-RELATED AML
3516PDF: 837HTML: 6696 -
LOW INCIDENCE RATE OF OPPORTUNISTIC AND VIRAL INFECTIONS DURING IMATINIB TREATMENT IN CHRONIC MYELOID LEUKEMIA PATIENTS IN EARLY AND LATE CHRONIC PHASE
1559PDF: 774HTML: 840jdoe, table 2 infections CML .doc: 177jdoe, table 1 infections CML .doc: 165







